Project
GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for HIC1
Z-value: 2.23
Motif logo
Transcription factors associated with HIC1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
HIC1
|
ENSG00000177374.8 | HIC ZBTB transcriptional repressor 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| HIC1 | hg19_v2_chr17_+_1959369_1959604, hg19_v2_chr17_+_1958388_1958404 | 0.40 | 1.0e-09 | Click! |
Activity profile of HIC1 motif
Sorted Z-values of HIC1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr1_+_6845384 | 77.19 |
ENST00000303635.7
|
CAMTA1
|
calmodulin binding transcription activator 1 |
| chr15_+_68871308 | 47.32 |
ENST00000261861.5
|
CORO2B
|
coronin, actin binding protein, 2B |
| chr16_+_58497567 | 43.51 |
ENST00000258187.5
|
NDRG4
|
NDRG family member 4 |
| chr19_+_709101 | 43.51 |
ENST00000338448.5
|
PALM
|
paralemmin |
| chr19_+_708910 | 42.23 |
ENST00000264560.7
|
PALM
|
paralemmin |
| chr16_+_1662326 | 41.01 |
ENST00000397412.3
|
CRAMP1L
|
Crm, cramped-like (Drosophila) |
| chr18_-_74844727 | 40.67 |
ENST00000355994.2
ENST00000579129.1 |
MBP
|
myelin basic protein |
| chr9_-_101471479 | 40.29 |
ENST00000259455.2
|
GABBR2
|
gamma-aminobutyric acid (GABA) B receptor, 2 |
| chr9_+_137979506 | 39.96 |
ENST00000539529.1
ENST00000392991.4 ENST00000371793.3 |
OLFM1
|
olfactomedin 1 |
| chr20_+_44034804 | 39.96 |
ENST00000357275.2
ENST00000372720.3 |
DBNDD2
|
dysbindin (dystrobrevin binding protein 1) domain containing 2 |
| chr4_-_109684120 | 39.96 |
ENST00000512646.1
ENST00000411864.2 ENST00000296486.3 ENST00000510706.1 |
ETNPPL
|
ethanolamine-phosphate phospho-lyase |
| chr19_+_35521572 | 36.67 |
ENST00000262631.5
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
| chr2_-_224903995 | 36.07 |
ENST00000409304.1
ENST00000454956.1 ENST00000258405.4 |
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
| chr16_+_226658 | 35.77 |
ENST00000320868.5
ENST00000397797.1 |
HBA1
|
hemoglobin, alpha 1 |
| chr19_+_35521616 | 35.23 |
ENST00000595652.1
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
| chrX_+_38420783 | 34.83 |
ENST00000422612.2
ENST00000286824.6 ENST00000545599.1 |
TSPAN7
|
tetraspanin 7 |
| chr6_-_84419101 | 34.37 |
ENST00000520302.1
ENST00000520213.1 ENST00000439399.2 ENST00000428679.2 ENST00000437520.1 |
SNAP91
|
synaptosomal-associated protein, 91kDa |
| chr12_-_45270151 | 32.53 |
ENST00000429094.2
|
NELL2
|
NEL-like 2 (chicken) |
| chr7_-_44365020 | 32.37 |
ENST00000395747.2
ENST00000347193.4 ENST00000346990.4 ENST00000258682.6 ENST00000353625.4 ENST00000421607.1 ENST00000424197.1 ENST00000502837.2 ENST00000350811.3 ENST00000395749.2 |
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta |
| chr17_-_15903002 | 31.94 |
ENST00000399277.1
|
ZSWIM7
|
zinc finger, SWIM-type containing 7 |
| chr6_-_84418841 | 31.90 |
ENST00000369694.2
ENST00000195649.6 |
SNAP91
|
synaptosomal-associated protein, 91kDa |
| chr11_-_2160611 | 31.86 |
ENST00000416167.2
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chr12_-_45270077 | 31.75 |
ENST00000551601.1
ENST00000549027.1 ENST00000452445.2 |
NELL2
|
NEL-like 2 (chicken) |
| chrX_+_38420623 | 31.70 |
ENST00000378482.2
|
TSPAN7
|
tetraspanin 7 |
| chr18_+_77439775 | 31.31 |
ENST00000299543.7
ENST00000075430.7 |
CTDP1
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1 |
| chr10_+_121485588 | 31.04 |
ENST00000361976.2
ENST00000369083.3 |
INPP5F
|
inositol polyphosphate-5-phosphatase F |
| chr12_+_121078355 | 29.84 |
ENST00000316803.3
|
CABP1
|
calcium binding protein 1 |
| chr10_+_124221036 | 29.56 |
ENST00000368984.3
|
HTRA1
|
HtrA serine peptidase 1 |
| chr11_-_12030905 | 28.85 |
ENST00000326932.4
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
| chr16_-_1661988 | 28.76 |
ENST00000426508.2
|
IFT140
|
intraflagellar transport 140 homolog (Chlamydomonas) |
| chr20_+_44034676 | 28.62 |
ENST00000372723.3
ENST00000372722.3 |
DBNDD2
|
dysbindin (dystrobrevin binding protein 1) domain containing 2 |
| chr8_-_120685608 | 28.50 |
ENST00000427067.2
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
| chr5_+_134240588 | 28.14 |
ENST00000254908.6
|
PCBD2
|
pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) 2 |
| chr6_-_46459099 | 27.97 |
ENST00000371374.1
|
RCAN2
|
regulator of calcineurin 2 |
| chr13_+_42031679 | 27.78 |
ENST00000379359.3
|
RGCC
|
regulator of cell cycle |
| chr9_+_130374537 | 27.64 |
ENST00000373302.3
ENST00000373299.1 |
STXBP1
|
syntaxin binding protein 1 |
| chr15_+_80696666 | 27.13 |
ENST00000303329.4
|
ARNT2
|
aryl-hydrocarbon receptor nuclear translocator 2 |
| chr11_+_70244510 | 25.13 |
ENST00000346329.3
ENST00000301843.8 ENST00000376561.3 |
CTTN
|
cortactin |
| chr11_-_777467 | 24.81 |
ENST00000397472.2
ENST00000524550.1 ENST00000319863.8 ENST00000526325.1 ENST00000442059.2 |
PDDC1
|
Parkinson disease 7 domain containing 1 |
| chr15_+_68871569 | 24.61 |
ENST00000566799.1
|
CORO2B
|
coronin, actin binding protein, 2B |
| chr2_+_241938255 | 24.46 |
ENST00000401884.1
ENST00000405547.3 ENST00000310397.8 ENST00000342631.6 |
SNED1
|
sushi, nidogen and EGF-like domains 1 |
| chr2_-_99552620 | 23.85 |
ENST00000428096.1
ENST00000397899.2 ENST00000420294.1 |
KIAA1211L
|
KIAA1211-like |
| chr8_+_104152922 | 23.67 |
ENST00000309982.5
ENST00000438105.2 ENST00000297574.6 |
BAALC
|
brain and acute leukemia, cytoplasmic |
| chr14_+_102027688 | 23.43 |
ENST00000510508.4
ENST00000359323.3 |
DIO3
|
deiodinase, iodothyronine, type III |
| chr7_+_45613958 | 23.32 |
ENST00000297323.7
|
ADCY1
|
adenylate cyclase 1 (brain) |
| chr6_-_109330702 | 22.97 |
ENST00000356644.7
|
SESN1
|
sestrin 1 |
| chr2_-_38604398 | 22.43 |
ENST00000443098.1
ENST00000449130.1 ENST00000378954.4 ENST00000539122.1 ENST00000419554.2 ENST00000451483.1 ENST00000406122.1 |
ATL2
|
atlastin GTPase 2 |
| chr17_-_15165854 | 22.31 |
ENST00000395936.1
ENST00000395938.2 |
PMP22
|
peripheral myelin protein 22 |
| chr1_+_169075554 | 22.24 |
ENST00000367815.4
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
| chr20_+_44035200 | 22.06 |
ENST00000372717.1
ENST00000360981.4 |
DBNDD2
|
dysbindin (dystrobrevin binding protein 1) domain containing 2 |
| chr6_+_107811162 | 22.05 |
ENST00000317357.5
|
SOBP
|
sine oculis binding protein homolog (Drosophila) |
| chr1_+_10270863 | 22.04 |
ENST00000377093.4
ENST00000263934.6 |
KIF1B
|
kinesin family member 1B |
| chr12_+_53440753 | 21.82 |
ENST00000379902.3
|
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
| chr4_-_57522598 | 21.36 |
ENST00000553379.2
|
HOPX
|
HOP homeobox |
| chr3_+_53528659 | 21.30 |
ENST00000350061.5
|
CACNA1D
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
| chr8_-_101571964 | 21.22 |
ENST00000520552.1
ENST00000521345.1 ENST00000523000.1 ENST00000335659.3 ENST00000358990.3 ENST00000519597.1 |
ANKRD46
|
ankyrin repeat domain 46 |
| chr6_+_43543864 | 21.19 |
ENST00000372236.4
ENST00000535400.1 |
POLH
|
polymerase (DNA directed), eta |
| chr4_-_57522673 | 21.06 |
ENST00000381255.3
ENST00000317745.7 ENST00000555760.2 ENST00000556614.2 |
HOPX
|
HOP homeobox |
| chr22_+_33197683 | 21.04 |
ENST00000266085.6
|
TIMP3
|
TIMP metallopeptidase inhibitor 3 |
| chr17_+_30813576 | 20.93 |
ENST00000313401.3
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
| chr20_-_50384864 | 20.80 |
ENST00000311637.5
ENST00000402822.1 |
ATP9A
|
ATPase, class II, type 9A |
| chr20_-_50385138 | 20.74 |
ENST00000338821.5
|
ATP9A
|
ATPase, class II, type 9A |
| chr8_-_101571933 | 20.56 |
ENST00000520311.1
|
ANKRD46
|
ankyrin repeat domain 46 |
| chrX_-_2418596 | 20.55 |
ENST00000381218.3
|
ZBED1
|
zinc finger, BED-type containing 1 |
| chr1_-_241520525 | 20.47 |
ENST00000366565.1
|
RGS7
|
regulator of G-protein signaling 7 |
| chr7_+_4721885 | 20.46 |
ENST00000328914.4
|
FOXK1
|
forkhead box K1 |
| chr9_+_17579084 | 20.29 |
ENST00000380607.4
|
SH3GL2
|
SH3-domain GRB2-like 2 |
| chr2_+_46524537 | 20.21 |
ENST00000263734.3
|
EPAS1
|
endothelial PAS domain protein 1 |
| chr6_-_56819385 | 20.19 |
ENST00000370754.5
ENST00000449297.2 |
DST
|
dystonin |
| chr10_-_81205373 | 20.09 |
ENST00000372336.3
|
ZCCHC24
|
zinc finger, CCHC domain containing 24 |
| chr9_+_137967366 | 20.05 |
ENST00000252854.4
|
OLFM1
|
olfactomedin 1 |
| chr17_-_74236382 | 20.02 |
ENST00000592271.1
ENST00000319945.6 ENST00000269391.6 |
RNF157
|
ring finger protein 157 |
| chr22_-_21213029 | 19.96 |
ENST00000572273.1
ENST00000255882.6 |
PI4KA
|
phosphatidylinositol 4-kinase, catalytic, alpha |
| chr11_-_66336060 | 19.81 |
ENST00000310325.5
|
CTSF
|
cathepsin F |
| chr16_+_84002234 | 19.81 |
ENST00000305202.4
|
NECAB2
|
N-terminal EF-hand calcium binding protein 2 |
| chr2_-_175870085 | 19.78 |
ENST00000409156.3
|
CHN1
|
chimerin 1 |
| chr10_+_126150369 | 19.66 |
ENST00000392757.4
ENST00000368842.5 ENST00000368839.1 |
LHPP
|
phospholysine phosphohistidine inorganic pyrophosphate phosphatase |
| chr19_-_460996 | 19.62 |
ENST00000264554.6
|
SHC2
|
SHC (Src homology 2 domain containing) transforming protein 2 |
| chr17_-_79139817 | 19.34 |
ENST00000326724.4
|
AATK
|
apoptosis-associated tyrosine kinase |
| chr4_-_57522470 | 19.33 |
ENST00000503639.3
|
HOPX
|
HOP homeobox |
| chr19_-_19006890 | 19.32 |
ENST00000247005.6
|
GDF1
|
growth differentiation factor 1 |
| chr8_+_1922024 | 19.22 |
ENST00000320248.3
|
KBTBD11
|
kelch repeat and BTB (POZ) domain containing 11 |
| chr19_-_42746714 | 19.16 |
ENST00000222330.3
|
GSK3A
|
glycogen synthase kinase 3 alpha |
| chr22_-_45559642 | 19.05 |
ENST00000426282.2
|
CTA-217C2.1
|
CTA-217C2.1 |
| chr2_+_20646824 | 18.86 |
ENST00000272233.4
|
RHOB
|
ras homolog family member B |
| chr6_-_84418860 | 18.84 |
ENST00000521743.1
|
SNAP91
|
synaptosomal-associated protein, 91kDa |
| chr16_+_66914264 | 18.81 |
ENST00000311765.2
ENST00000568869.1 ENST00000561704.1 ENST00000568398.1 ENST00000566776.1 |
PDP2
|
pyruvate dehyrogenase phosphatase catalytic subunit 2 |
| chr19_-_49944806 | 18.74 |
ENST00000221485.3
|
SLC17A7
|
solute carrier family 17 (vesicular glutamate transporter), member 7 |
| chr17_+_38083977 | 18.60 |
ENST00000578802.1
ENST00000578478.1 ENST00000582263.1 |
RP11-387H17.4
|
RP11-387H17.4 |
| chr7_-_99756293 | 18.54 |
ENST00000316937.3
ENST00000456769.1 |
C7orf43
|
chromosome 7 open reading frame 43 |
| chr3_+_32147997 | 18.48 |
ENST00000282541.5
|
GPD1L
|
glycerol-3-phosphate dehydrogenase 1-like |
| chr4_+_3768075 | 18.45 |
ENST00000509482.1
ENST00000330055.5 |
ADRA2C
|
adrenoceptor alpha 2C |
| chr17_-_80656528 | 18.37 |
ENST00000538809.2
ENST00000269347.6 ENST00000571995.1 |
RAB40B
|
RAB40B, member RAS oncogene family |
| chr2_-_175869936 | 18.35 |
ENST00000409900.3
|
CHN1
|
chimerin 1 |
| chr4_+_1795012 | 18.18 |
ENST00000481110.2
ENST00000340107.4 ENST00000440486.2 ENST00000412135.2 |
FGFR3
|
fibroblast growth factor receptor 3 |
| chr19_+_18718214 | 17.77 |
ENST00000600490.1
|
TMEM59L
|
transmembrane protein 59-like |
| chr3_+_49027308 | 17.76 |
ENST00000383729.4
ENST00000343546.4 |
P4HTM
|
prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum) |
| chr5_+_76506706 | 17.60 |
ENST00000340978.3
ENST00000346042.3 ENST00000264917.5 ENST00000342343.4 ENST00000333194.4 |
PDE8B
|
phosphodiesterase 8B |
| chrX_+_110187513 | 17.56 |
ENST00000446737.1
ENST00000425146.1 |
PAK3
|
p21 protein (Cdc42/Rac)-activated kinase 3 |
| chr12_-_124457371 | 17.49 |
ENST00000238156.3
ENST00000545037.1 |
CCDC92
|
coiled-coil domain containing 92 |
| chr21_-_34100244 | 17.47 |
ENST00000382491.3
ENST00000357345.3 ENST00000429236.1 |
SYNJ1
|
synaptojanin 1 |
| chr9_-_139922631 | 17.46 |
ENST00000341511.6
|
ABCA2
|
ATP-binding cassette, sub-family A (ABC1), member 2 |
| chr4_+_2965307 | 17.41 |
ENST00000398051.4
ENST00000503518.2 ENST00000398052.4 ENST00000345167.6 ENST00000504933.1 ENST00000442472.2 |
GRK4
|
G protein-coupled receptor kinase 4 |
| chr7_-_22396533 | 17.38 |
ENST00000344041.6
|
RAPGEF5
|
Rap guanine nucleotide exchange factor (GEF) 5 |
| chr3_-_149688502 | 17.17 |
ENST00000481767.1
ENST00000475518.1 |
PFN2
|
profilin 2 |
| chr1_-_6240183 | 17.14 |
ENST00000262450.3
ENST00000378021.1 |
CHD5
|
chromodomain helicase DNA binding protein 5 |
| chr7_-_124405681 | 17.13 |
ENST00000303921.2
|
GPR37
|
G protein-coupled receptor 37 (endothelin receptor type B-like) |
| chr22_-_39239987 | 17.05 |
ENST00000333039.2
|
NPTXR
|
neuronal pentraxin receptor |
| chr6_+_147830063 | 16.93 |
ENST00000367474.1
|
SAMD5
|
sterile alpha motif domain containing 5 |
| chr12_-_53574376 | 16.90 |
ENST00000267085.4
ENST00000379850.3 ENST00000379846.1 ENST00000424990.1 |
CSAD
|
cysteine sulfinic acid decarboxylase |
| chr11_-_108369101 | 16.90 |
ENST00000323468.5
|
KDELC2
|
KDEL (Lys-Asp-Glu-Leu) containing 2 |
| chr14_+_65171099 | 16.87 |
ENST00000247226.7
|
PLEKHG3
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 3 |
| chr6_+_43543942 | 16.87 |
ENST00000372226.1
ENST00000443535.1 |
POLH
|
polymerase (DNA directed), eta |
| chr15_-_71146480 | 16.87 |
ENST00000299213.8
|
LARP6
|
La ribonucleoprotein domain family, member 6 |
| chr2_+_220379052 | 16.78 |
ENST00000347842.3
ENST00000358078.4 |
ASIC4
|
acid-sensing (proton-gated) ion channel family member 4 |
| chr6_+_31865552 | 16.68 |
ENST00000469372.1
ENST00000497706.1 |
C2
|
complement component 2 |
| chr2_-_86564776 | 16.66 |
ENST00000165698.5
ENST00000541910.1 ENST00000535845.1 |
REEP1
|
receptor accessory protein 1 |
| chr1_+_184356188 | 16.63 |
ENST00000235307.6
|
C1orf21
|
chromosome 1 open reading frame 21 |
| chr14_+_73704201 | 16.60 |
ENST00000340738.5
ENST00000427855.1 ENST00000381166.3 |
PAPLN
|
papilin, proteoglycan-like sulfated glycoprotein |
| chr9_+_124030338 | 16.53 |
ENST00000449773.1
ENST00000432226.1 ENST00000436847.1 ENST00000394353.2 ENST00000449733.1 ENST00000412819.1 ENST00000341272.2 ENST00000373808.2 |
GSN
|
gelsolin |
| chr8_+_136469684 | 16.52 |
ENST00000355849.5
|
KHDRBS3
|
KH domain containing, RNA binding, signal transduction associated 3 |
| chr16_+_3096638 | 16.44 |
ENST00000336577.4
|
MMP25
|
matrix metallopeptidase 25 |
| chr1_+_24882560 | 16.31 |
ENST00000374392.2
|
NCMAP
|
noncompact myelin associated protein |
| chr20_-_48532019 | 16.13 |
ENST00000289431.5
|
SPATA2
|
spermatogenesis associated 2 |
| chr14_+_96505659 | 16.11 |
ENST00000555004.1
|
C14orf132
|
chromosome 14 open reading frame 132 |
| chr3_-_149688655 | 16.08 |
ENST00000461930.1
ENST00000423691.2 ENST00000490975.1 ENST00000461868.1 ENST00000452853.2 |
PFN2
|
profilin 2 |
| chr5_-_146889619 | 16.05 |
ENST00000343218.5
|
DPYSL3
|
dihydropyrimidinase-like 3 |
| chr12_-_53574418 | 16.01 |
ENST00000379843.3
ENST00000453446.2 ENST00000437073.1 |
CSAD
|
cysteine sulfinic acid decarboxylase |
| chr18_-_72265035 | 15.94 |
ENST00000585279.1
ENST00000580048.1 |
LINC00909
|
long intergenic non-protein coding RNA 909 |
| chr8_-_110703819 | 15.93 |
ENST00000532779.1
ENST00000534578.1 |
SYBU
|
syntabulin (syntaxin-interacting) |
| chr19_-_18717627 | 15.74 |
ENST00000392386.3
|
CRLF1
|
cytokine receptor-like factor 1 |
| chr1_+_9599540 | 15.74 |
ENST00000302692.6
|
SLC25A33
|
solute carrier family 25 (pyrimidine nucleotide carrier), member 33 |
| chr4_-_5890145 | 15.48 |
ENST00000397890.2
|
CRMP1
|
collapsin response mediator protein 1 |
| chr11_-_62389449 | 15.47 |
ENST00000534026.1
|
B3GAT3
|
beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) |
| chr9_-_91793675 | 15.41 |
ENST00000375835.4
ENST00000375830.1 |
SHC3
|
SHC (Src homology 2 domain containing) transforming protein 3 |
| chr21_-_38338773 | 15.40 |
ENST00000399120.1
ENST00000419461.1 |
HLCS
|
holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase) |
| chr9_-_139922726 | 15.31 |
ENST00000265662.5
ENST00000371605.3 |
ABCA2
|
ATP-binding cassette, sub-family A (ABC1), member 2 |
| chr20_+_23016057 | 15.20 |
ENST00000255008.3
|
SSTR4
|
somatostatin receptor 4 |
| chr4_+_4388805 | 15.16 |
ENST00000504171.1
|
NSG1
|
Homo sapiens neuron specific gene family member 1 (NSG1), transcript variant 3, mRNA. |
| chr4_-_5894777 | 15.07 |
ENST00000324989.7
|
CRMP1
|
collapsin response mediator protein 1 |
| chr19_+_33685490 | 15.07 |
ENST00000253193.7
|
LRP3
|
low density lipoprotein receptor-related protein 3 |
| chr13_+_27131887 | 14.92 |
ENST00000335327.5
|
WASF3
|
WAS protein family, member 3 |
| chr1_+_3569072 | 14.87 |
ENST00000378295.4
ENST00000604074.1 |
TP73
|
tumor protein p73 |
| chr1_-_11865982 | 14.86 |
ENST00000418034.1
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H) |
| chr21_-_34100341 | 14.78 |
ENST00000382499.2
ENST00000433931.2 |
SYNJ1
|
synaptojanin 1 |
| chr15_-_72410350 | 14.71 |
ENST00000356056.5
ENST00000424560.1 ENST00000444904.1 |
MYO9A
|
myosin IXA |
| chr9_-_140353748 | 14.57 |
ENST00000371472.2
ENST00000371475.3 ENST00000265663.7 ENST00000437259.1 ENST00000392812.4 ENST00000371474.3 ENST00000371473.3 |
NSMF
|
NMDA receptor synaptonuclear signaling and neuronal migration factor |
| chr15_+_29131103 | 14.49 |
ENST00000558402.1
ENST00000558330.1 |
APBA2
|
amyloid beta (A4) precursor protein-binding, family A, member 2 |
| chr19_+_16999654 | 14.49 |
ENST00000248076.3
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3 |
| chr19_-_19006920 | 14.44 |
ENST00000429504.2
ENST00000427170.2 |
CERS1
|
ceramide synthase 1 |
| chr16_+_85061367 | 14.41 |
ENST00000538274.1
ENST00000258180.3 |
KIAA0513
|
KIAA0513 |
| chr6_+_19837592 | 14.28 |
ENST00000378700.3
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein |
| chr12_+_12878829 | 14.24 |
ENST00000326765.6
|
APOLD1
|
apolipoprotein L domain containing 1 |
| chr19_-_2236290 | 14.21 |
ENST00000591099.2
ENST00000586608.2 ENST00000326631.2 ENST00000587962.2 |
PLEKHJ1
|
pleckstrin homology domain containing, family J member 1 |
| chr1_+_3569129 | 14.14 |
ENST00000354437.4
ENST00000357733.3 ENST00000346387.4 |
TP73
|
tumor protein p73 |
| chr19_+_10541462 | 14.13 |
ENST00000293683.5
|
PDE4A
|
phosphodiesterase 4A, cAMP-specific |
| chr8_+_124194752 | 14.06 |
ENST00000318462.6
|
FAM83A
|
family with sequence similarity 83, member A |
| chr3_-_52001448 | 14.05 |
ENST00000461554.1
ENST00000395013.3 ENST00000428823.2 ENST00000483411.1 ENST00000461544.1 ENST00000355852.2 |
PCBP4
|
poly(rC) binding protein 4 |
| chrX_-_153363188 | 14.05 |
ENST00000303391.6
|
MECP2
|
methyl CpG binding protein 2 (Rett syndrome) |
| chr9_-_136857403 | 14.03 |
ENST00000406606.3
ENST00000371850.3 |
VAV2
|
vav 2 guanine nucleotide exchange factor |
| chr8_+_26435359 | 14.02 |
ENST00000311151.5
|
DPYSL2
|
dihydropyrimidinase-like 2 |
| chr1_-_21948906 | 13.94 |
ENST00000374761.2
ENST00000599760.1 |
RAP1GAP
|
RAP1 GTPase activating protein |
| chr16_+_1756162 | 13.90 |
ENST00000250894.4
ENST00000356010.5 |
MAPK8IP3
|
mitogen-activated protein kinase 8 interacting protein 3 |
| chr1_-_54872059 | 13.85 |
ENST00000371320.3
|
SSBP3
|
single stranded DNA binding protein 3 |
| chr17_-_10101868 | 13.74 |
ENST00000432992.2
ENST00000540214.1 |
GAS7
|
growth arrest-specific 7 |
| chrX_-_8700171 | 13.72 |
ENST00000262648.3
|
KAL1
|
Kallmann syndrome 1 sequence |
| chr5_+_149109825 | 13.71 |
ENST00000360453.4
ENST00000394320.3 ENST00000309241.5 |
PPARGC1B
|
peroxisome proliferator-activated receptor gamma, coactivator 1 beta |
| chr7_+_98246588 | 13.71 |
ENST00000265634.3
|
NPTX2
|
neuronal pentraxin II |
| chr1_-_21995794 | 13.70 |
ENST00000542643.2
ENST00000374765.4 ENST00000317967.7 |
RAP1GAP
|
RAP1 GTPase activating protein |
| chr17_+_18163848 | 13.68 |
ENST00000323019.4
ENST00000578174.1 ENST00000395704.4 ENST00000395703.4 ENST00000578621.1 ENST00000579341.1 |
MIEF2
|
mitochondrial elongation factor 2 |
| chr12_+_113376249 | 13.62 |
ENST00000551007.1
ENST00000548514.1 |
OAS3
|
2'-5'-oligoadenylate synthetase 3, 100kDa |
| chr9_-_13279563 | 13.58 |
ENST00000541718.1
|
MPDZ
|
multiple PDZ domain protein |
| chr1_+_156611704 | 13.56 |
ENST00000329117.5
|
BCAN
|
brevican |
| chr12_+_119616447 | 13.54 |
ENST00000281938.2
|
HSPB8
|
heat shock 22kDa protein 8 |
| chr16_-_75498308 | 13.52 |
ENST00000569540.1
|
TMEM170A
|
transmembrane protein 170A |
| chr2_-_183903133 | 13.49 |
ENST00000361354.4
|
NCKAP1
|
NCK-associated protein 1 |
| chr7_-_122526799 | 13.33 |
ENST00000334010.7
ENST00000313070.7 |
CADPS2
|
Ca++-dependent secretion activator 2 |
| chr14_+_33408449 | 13.30 |
ENST00000346562.2
ENST00000341321.4 ENST00000548645.1 ENST00000356141.4 ENST00000357798.5 |
NPAS3
|
neuronal PAS domain protein 3 |
| chr11_+_121322832 | 13.29 |
ENST00000260197.7
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing |
| chr20_-_35492048 | 13.27 |
ENST00000237536.4
|
SOGA1
|
suppressor of glucose, autophagy associated 1 |
| chr3_-_127541679 | 13.25 |
ENST00000265052.5
|
MGLL
|
monoglyceride lipase |
| chr3_+_14989186 | 13.19 |
ENST00000435454.1
ENST00000323373.6 |
NR2C2
|
nuclear receptor subfamily 2, group C, member 2 |
| chr7_+_2559399 | 13.17 |
ENST00000222725.5
ENST00000359574.3 |
LFNG
|
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
| chr1_-_85930823 | 13.16 |
ENST00000284031.8
ENST00000539042.1 |
DDAH1
|
dimethylarginine dimethylaminohydrolase 1 |
| chr20_+_4667094 | 13.16 |
ENST00000424424.1
ENST00000457586.1 |
PRNP
|
prion protein |
| chr9_+_129089088 | 13.15 |
ENST00000361171.3
ENST00000545391.1 |
MVB12B
|
multivesicular body subunit 12B |
| chr7_-_73133959 | 13.07 |
ENST00000395155.3
ENST00000395154.3 ENST00000222812.3 ENST00000395156.3 |
STX1A
|
syntaxin 1A (brain) |
| chr8_+_104513086 | 13.06 |
ENST00000406091.3
|
RIMS2
|
regulating synaptic membrane exocytosis 2 |
| chr3_-_149688896 | 13.04 |
ENST00000239940.7
|
PFN2
|
profilin 2 |
| chr8_-_33424636 | 13.03 |
ENST00000256257.1
|
RNF122
|
ring finger protein 122 |
| chr12_-_53574671 | 13.01 |
ENST00000444623.1
|
CSAD
|
cysteine sulfinic acid decarboxylase |
| chr14_-_101034407 | 12.92 |
ENST00000443071.2
ENST00000557378.1 |
BEGAIN
|
brain-enriched guanylate kinase-associated |
| chr17_-_4167142 | 12.88 |
ENST00000570535.1
ENST00000574367.1 ENST00000341657.4 ENST00000433651.1 |
ANKFY1
|
ankyrin repeat and FYVE domain containing 1 |
| chr19_-_49140609 | 12.87 |
ENST00000601104.1
|
DBP
|
D site of albumin promoter (albumin D-box) binding protein |
| chr10_-_120514720 | 12.87 |
ENST00000369151.3
ENST00000340214.4 |
CACUL1
|
CDK2-associated, cullin domain 1 |
| chr21_+_47878757 | 12.78 |
ENST00000400274.1
ENST00000427143.2 ENST00000318711.7 ENST00000457905.3 ENST00000466639.1 ENST00000435722.3 ENST00000417564.2 |
DIP2A
|
DIP2 disco-interacting protein 2 homolog A (Drosophila) |
| chr9_-_130742792 | 12.77 |
ENST00000373095.1
|
FAM102A
|
family with sequence similarity 102, member A |
| chr1_-_241520385 | 12.76 |
ENST00000366564.1
|
RGS7
|
regulator of G-protein signaling 7 |
| chr12_-_112819896 | 12.73 |
ENST00000377560.5
ENST00000430131.2 ENST00000550722.1 ENST00000550724.1 |
HECTD4
|
HECT domain containing E3 ubiquitin protein ligase 4 |
| chr12_+_125478241 | 12.67 |
ENST00000341446.8
|
BRI3BP
|
BRI3 binding protein |
Network of associatons between targets according to the STRING database.
First level regulatory network of HIC1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 24.0 | 71.9 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
| 11.5 | 45.9 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 11.0 | 88.3 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 10.4 | 31.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 10.2 | 30.5 | GO:1904617 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 10.1 | 50.4 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 9.4 | 18.7 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 9.3 | 27.8 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 9.2 | 27.7 | GO:0021718 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 9.2 | 27.6 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 9.2 | 27.6 | GO:0007412 | axon target recognition(GO:0007412) regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 9.0 | 36.0 | GO:1904978 | regulation of endosome organization(GO:1904978) |
| 8.7 | 78.7 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
| 7.4 | 22.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 7.3 | 22.0 | GO:1904647 | response to rotenone(GO:1904647) |
| 7.2 | 28.8 | GO:1990262 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 7.2 | 21.5 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 7.2 | 14.4 | GO:0072134 | nephrogenic mesenchyme morphogenesis(GO:0072134) |
| 7.0 | 34.9 | GO:1904209 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 6.8 | 87.8 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
| 6.6 | 19.8 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 6.6 | 32.8 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 6.5 | 91.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 6.4 | 19.2 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
| 6.1 | 12.2 | GO:1990523 | bone regeneration(GO:1990523) |
| 6.0 | 18.1 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 5.9 | 29.6 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
| 5.6 | 22.2 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 5.5 | 22.2 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 5.4 | 38.1 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 5.4 | 16.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 5.4 | 16.3 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 5.3 | 21.0 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 5.2 | 15.7 | GO:1990519 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 5.1 | 15.4 | GO:0070781 | response to biotin(GO:0070781) |
| 4.9 | 19.6 | GO:0060594 | mammary gland specification(GO:0060594) |
| 4.7 | 56.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 4.6 | 60.4 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 4.6 | 18.5 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) negative regulation of protein kinase C signaling(GO:0090038) |
| 4.6 | 18.4 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 4.5 | 4.5 | GO:2000583 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
| 4.4 | 39.5 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 4.2 | 46.1 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
| 4.2 | 12.5 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
| 4.2 | 12.5 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
| 4.1 | 20.6 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 4.1 | 8.1 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 4.1 | 12.2 | GO:0003383 | apical constriction(GO:0003383) mesoderm migration involved in gastrulation(GO:0007509) |
| 4.1 | 20.3 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 4.1 | 12.2 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 3.9 | 7.7 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
| 3.8 | 11.5 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 3.7 | 22.4 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 3.7 | 29.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 3.7 | 106.4 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 3.7 | 25.6 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
| 3.6 | 14.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
| 3.5 | 17.5 | GO:0097338 | response to clozapine(GO:0097338) |
| 3.5 | 27.6 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 3.3 | 23.4 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 3.3 | 10.0 | GO:0048511 | rhythmic process(GO:0048511) |
| 3.3 | 9.9 | GO:0071529 | cementum mineralization(GO:0071529) |
| 3.3 | 16.5 | GO:0044858 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 3.3 | 13.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
| 3.2 | 9.7 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 3.2 | 28.8 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 3.2 | 28.4 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 3.1 | 12.5 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
| 3.1 | 9.4 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
| 3.1 | 6.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 3.1 | 15.3 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 3.1 | 12.2 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 3.0 | 15.2 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 3.0 | 14.9 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 2.9 | 11.7 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
| 2.9 | 20.4 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
| 2.9 | 5.8 | GO:0021586 | pons maturation(GO:0021586) |
| 2.9 | 11.4 | GO:2001151 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 2.9 | 11.4 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
| 2.8 | 8.5 | GO:1900369 | transcription, RNA-templated(GO:0001172) regulation of RNA interference(GO:1900368) negative regulation of RNA interference(GO:1900369) positive regulation of protein localization to nucleolus(GO:1904751) |
| 2.8 | 11.3 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 2.8 | 11.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 2.7 | 8.2 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
| 2.7 | 10.9 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 2.7 | 8.1 | GO:0060437 | lung growth(GO:0060437) |
| 2.7 | 8.0 | GO:0031052 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
| 2.7 | 5.3 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
| 2.7 | 13.3 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 2.6 | 13.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 2.6 | 18.2 | GO:0060992 | response to fungicide(GO:0060992) |
| 2.6 | 23.0 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 2.5 | 20.2 | GO:0043129 | surfactant homeostasis(GO:0043129) |
| 2.5 | 12.6 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 2.5 | 22.2 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 2.5 | 12.3 | GO:1904139 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) positive regulation of microglial cell migration(GO:1904141) |
| 2.5 | 7.4 | GO:0044771 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 2.4 | 4.9 | GO:0070256 | negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 2.4 | 2.4 | GO:0007497 | posterior midgut development(GO:0007497) |
| 2.4 | 35.8 | GO:0015671 | oxygen transport(GO:0015671) |
| 2.4 | 7.1 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
| 2.4 | 9.4 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
| 2.3 | 11.4 | GO:0071321 | cellular response to cGMP(GO:0071321) |
| 2.3 | 27.2 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 2.3 | 9.0 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 2.2 | 6.6 | GO:0071373 | luteinizing hormone signaling pathway(GO:0042700) cellular response to luteinizing hormone stimulus(GO:0071373) |
| 2.2 | 24.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
| 2.2 | 13.2 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
| 2.2 | 6.5 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 2.2 | 10.9 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 2.1 | 12.9 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 2.1 | 8.5 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
| 2.1 | 6.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 2.1 | 10.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 2.0 | 10.1 | GO:0030035 | microspike assembly(GO:0030035) |
| 2.0 | 44.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 2.0 | 30.2 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 2.0 | 8.0 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 2.0 | 5.9 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 2.0 | 17.8 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
| 2.0 | 41.4 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 1.9 | 5.8 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 1.9 | 11.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 1.9 | 5.8 | GO:0072177 | mesonephric duct development(GO:0072177) |
| 1.9 | 9.7 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 1.9 | 9.6 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 1.9 | 9.5 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 1.9 | 5.7 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 1.9 | 13.2 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 1.9 | 35.8 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 1.9 | 20.6 | GO:0060022 | hard palate development(GO:0060022) |
| 1.9 | 7.5 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
| 1.9 | 13.1 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 1.9 | 5.6 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 1.8 | 12.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 1.8 | 9.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 1.8 | 14.5 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 1.8 | 5.4 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 1.8 | 19.9 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
| 1.8 | 10.7 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
| 1.8 | 5.3 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 1.8 | 5.3 | GO:0100009 | circadian temperature homeostasis(GO:0060086) regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 1.8 | 22.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 1.7 | 45.1 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 1.7 | 5.2 | GO:2000173 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 1.7 | 6.9 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 1.7 | 13.7 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 1.7 | 5.1 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 1.7 | 17.1 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 1.7 | 29.0 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
| 1.7 | 5.0 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 1.7 | 6.7 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 1.7 | 16.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 1.7 | 52.8 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
| 1.6 | 9.9 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 1.6 | 8.2 | GO:0090650 | rRNA transport(GO:0051029) response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 1.6 | 4.9 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 1.6 | 19.5 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 1.6 | 8.0 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 1.6 | 4.8 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 1.6 | 9.5 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 1.5 | 6.2 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 1.5 | 12.4 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 1.5 | 47.4 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 1.5 | 4.6 | GO:0097359 | UDP-glucosylation(GO:0097359) |
| 1.5 | 4.6 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
| 1.5 | 9.1 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 1.5 | 16.7 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 1.5 | 7.6 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 1.5 | 6.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 1.5 | 14.9 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
| 1.5 | 11.9 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 1.5 | 14.6 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 1.4 | 1.4 | GO:0003343 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
| 1.4 | 8.6 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
| 1.4 | 50.0 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
| 1.4 | 2.9 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 1.4 | 8.5 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 1.4 | 8.5 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 1.4 | 6.9 | GO:0099538 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 1.4 | 9.7 | GO:0051639 | actin filament network formation(GO:0051639) |
| 1.4 | 13.7 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
| 1.4 | 6.8 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 1.3 | 9.4 | GO:0043634 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 1.3 | 9.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 1.3 | 10.7 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
| 1.3 | 17.4 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
| 1.3 | 6.7 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 1.3 | 8.0 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 1.3 | 4.0 | GO:0090298 | negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
| 1.3 | 7.8 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
| 1.3 | 7.8 | GO:0098722 | asymmetric neuroblast division(GO:0055059) asymmetric stem cell division(GO:0098722) |
| 1.3 | 23.3 | GO:0032060 | bleb assembly(GO:0032060) |
| 1.3 | 6.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 1.3 | 6.4 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
| 1.3 | 19.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 1.3 | 3.8 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 1.3 | 46.4 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
| 1.3 | 12.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 1.3 | 6.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) minus-end-directed organelle transport along microtubule(GO:0072385) |
| 1.2 | 7.4 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 1.2 | 3.7 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 1.2 | 7.1 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
| 1.2 | 3.5 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
| 1.2 | 3.5 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 1.2 | 10.6 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
| 1.2 | 8.2 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
| 1.1 | 3.4 | GO:0043068 | positive regulation of apoptotic process(GO:0043065) positive regulation of programmed cell death(GO:0043068) |
| 1.1 | 17.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 1.1 | 6.5 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
| 1.1 | 8.7 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
| 1.1 | 11.9 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 1.1 | 3.2 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 1.1 | 2.1 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) endocardial cell differentiation(GO:0060956) |
| 1.1 | 2.1 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 1.1 | 6.4 | GO:0060013 | righting reflex(GO:0060013) |
| 1.1 | 10.6 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 1.1 | 2.1 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 1.1 | 10.6 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 1.0 | 19.8 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
| 1.0 | 5.2 | GO:0009636 | response to toxic substance(GO:0009636) |
| 1.0 | 7.2 | GO:0016322 | neuron remodeling(GO:0016322) |
| 1.0 | 59.3 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
| 1.0 | 6.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 1.0 | 2.0 | GO:0098868 | endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
| 1.0 | 9.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 1.0 | 5.0 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 1.0 | 8.9 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 1.0 | 3.9 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 1.0 | 4.9 | GO:0061511 | centriole elongation(GO:0061511) |
| 1.0 | 13.7 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 1.0 | 24.4 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 1.0 | 6.8 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 1.0 | 23.2 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 1.0 | 1.0 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
| 1.0 | 11.6 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 1.0 | 6.7 | GO:0046618 | drug export(GO:0046618) |
| 1.0 | 5.7 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
| 1.0 | 11.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 1.0 | 3.8 | GO:0030705 | cytoskeleton-dependent intracellular transport(GO:0030705) |
| 1.0 | 10.5 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.9 | 32.4 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.9 | 7.4 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
| 0.9 | 21.2 | GO:0031643 | positive regulation of myelination(GO:0031643) |
| 0.9 | 3.7 | GO:0019086 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) late viral transcription(GO:0019086) positive regulation of transcription by glucose(GO:0046016) |
| 0.9 | 9.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.9 | 0.9 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.9 | 16.3 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.9 | 11.7 | GO:0008089 | anterograde axonal transport(GO:0008089) |
| 0.9 | 7.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.9 | 7.2 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.9 | 5.3 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
| 0.9 | 16.0 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.9 | 8.9 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
| 0.9 | 9.7 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
| 0.9 | 2.6 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
| 0.8 | 6.8 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.8 | 8.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.8 | 8.5 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.8 | 1.7 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.8 | 7.5 | GO:0006338 | chromatin remodeling(GO:0006338) |
| 0.8 | 5.0 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.8 | 2.5 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.8 | 7.4 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
| 0.8 | 5.7 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
| 0.8 | 9.7 | GO:0014848 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
| 0.8 | 3.9 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.8 | 6.2 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
| 0.8 | 14.7 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
| 0.8 | 4.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.7 | 19.4 | GO:0097503 | sialylation(GO:0097503) |
| 0.7 | 3.7 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
| 0.7 | 14.7 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.7 | 7.3 | GO:0030913 | paranodal junction assembly(GO:0030913) |
| 0.7 | 5.1 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
| 0.7 | 2.2 | GO:1903401 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine transmembrane transport(GO:1903401) L-lysine import into cell(GO:1903410) |
| 0.7 | 11.5 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.7 | 11.4 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.7 | 2.1 | GO:0050720 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.7 | 3.6 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.7 | 3.5 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
| 0.7 | 5.6 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
| 0.7 | 2.1 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.7 | 4.8 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.7 | 22.0 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.7 | 10.9 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.7 | 11.5 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
| 0.7 | 3.3 | GO:0060004 | reflex(GO:0060004) |
| 0.7 | 15.2 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
| 0.7 | 2.0 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.7 | 9.3 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.7 | 5.3 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.7 | 2.6 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.7 | 9.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.7 | 3.9 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
| 0.6 | 1.9 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.6 | 1.9 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 0.6 | 1.9 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.6 | 1.2 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.6 | 7.7 | GO:0048820 | hair follicle maturation(GO:0048820) |
| 0.6 | 5.9 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.6 | 11.9 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.6 | 5.9 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
| 0.6 | 5.3 | GO:0046578 | regulation of Ras protein signal transduction(GO:0046578) |
| 0.6 | 1.7 | GO:0021997 | neural plate axis specification(GO:0021997) |
| 0.6 | 5.7 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
| 0.6 | 2.3 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.6 | 5.7 | GO:0060841 | venous blood vessel development(GO:0060841) |
| 0.6 | 1.7 | GO:0009447 | putrescine catabolic process(GO:0009447) |
| 0.6 | 3.4 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.6 | 2.2 | GO:0007018 | microtubule-based movement(GO:0007018) |
| 0.6 | 6.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.5 | 1.6 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.5 | 3.8 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.5 | 7.6 | GO:0021854 | hypothalamus development(GO:0021854) |
| 0.5 | 5.4 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.5 | 4.3 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
| 0.5 | 3.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.5 | 1.6 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.5 | 9.9 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
| 0.5 | 3.6 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.5 | 2.6 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.5 | 4.1 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.5 | 31.9 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
| 0.5 | 9.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.5 | 9.2 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.5 | 4.5 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
| 0.5 | 8.0 | GO:0030032 | lamellipodium assembly(GO:0030032) |
| 0.5 | 10.5 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.5 | 4.0 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.5 | 12.3 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.5 | 2.0 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.5 | 0.5 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
| 0.5 | 4.9 | GO:0008038 | neuron recognition(GO:0008038) |
| 0.5 | 12.0 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.5 | 3.3 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.5 | 12.3 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.5 | 15.5 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
| 0.5 | 1.9 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.5 | 0.5 | GO:0072178 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
| 0.5 | 8.7 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
| 0.5 | 1.4 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.5 | 4.1 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.4 | 13.9 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.4 | 1.8 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.4 | 1.8 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
| 0.4 | 4.4 | GO:0055123 | digestive system development(GO:0055123) |
| 0.4 | 3.0 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
| 0.4 | 6.7 | GO:0030030 | cell projection organization(GO:0030030) |
| 0.4 | 1.3 | GO:0072284 | thyroid-stimulating hormone secretion(GO:0070460) comma-shaped body morphogenesis(GO:0072049) S-shaped body morphogenesis(GO:0072050) metanephric comma-shaped body morphogenesis(GO:0072278) metanephric S-shaped body morphogenesis(GO:0072284) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 0.4 | 6.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.4 | 2.5 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.4 | 1.2 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine salvage(GO:0071267) |
| 0.4 | 5.7 | GO:0009650 | UV protection(GO:0009650) |
| 0.4 | 3.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.4 | 3.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.4 | 2.8 | GO:0048710 | regulation of astrocyte differentiation(GO:0048710) |
| 0.4 | 2.4 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.4 | 9.0 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
| 0.4 | 3.1 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
| 0.4 | 8.5 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.4 | 2.3 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.4 | 2.7 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
| 0.4 | 3.0 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.4 | 20.7 | GO:0030516 | regulation of axon extension(GO:0030516) |
| 0.4 | 12.5 | GO:0090102 | cochlea development(GO:0090102) |
| 0.4 | 5.1 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.4 | 9.7 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.4 | 9.3 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.4 | 1.4 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 0.3 | 4.2 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 0.3 | 2.4 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
| 0.3 | 15.0 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.3 | 1.3 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
| 0.3 |